Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: A nationwide population-based study

S. H. Chien, C. J. Liu, Y. C. Hong, C. J. Teng, Y. W. Hu, C. C. Shen, F. C. Ku, S. C. Chen, C. M. Yeh, T. J. Chiou, J. P. Gau, C. H. Tzeng

研究成果: 雜誌貢獻文章同行評審

18 引文 斯高帕斯(Scopus)

摘要

Background: As more patients are treated by haematopoietic stem cell transplantation (HSCT), development of secondary malignancy (SM) becomes an increasingly common issue in long-term survivors. Methods: We conducted a nationwide population-based study of the Taiwanese population to analyse patients who received HSCT between January 1997 and December 2010. Standardised incidence ratios (SIRs) were used to compare the risk of SM in HSCT patients and the general population. Multivariate analysis was performed to identify independent predictors of SM. Results: Patients receiving HSCT had a significantly greater risk of developing SM (SIR 2.00; 95% confidence interval (CI) 1.45-2.69; P
原文英語
頁(從 - 到)177-184
頁數8
期刊British Journal of Cancer
112
發行號1
DOIs
出版狀態已發佈 - 1月 2015
對外發佈

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究

指紋

深入研究「Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: A nationwide population-based study」主題。共同形成了獨特的指紋。

引用此